Indivior PLC Stock Forecast for 2023 - 2025 - 2030

Updated on 02/01/2023

Stock Rating
14
Price Target
£4.74
Consensus
Outperform
Downside
-97.40%
Analysts
1
Stock Rating
14
Downside
-97.40%
Analysts
1
Price Target
£4.74

Indivior PLC Stock Forecast and Price Target

The average target price set lately by experts for Indivior PLC to reach by the end of the year is £4.74, which would imply a potential downside of approximately -97.4 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of £5.09 and a low estimate of £3.93. Even if you are not interested in INDV stock, you should still be aware of its competitors.

£4.74

-97.40% Downside

Buy
Buy

Indivior PLC Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's Price has decreased from £2.13 to £1.67 – a 21.74% drop! The next year looks promising for Indivior PLC, with analysts predicting Fair Value of £2.09 – an increase of 25.46%. Over the next nine years, experts anticipate that Indivior PLC's Fair Value will grow at a rate of 26.02%.

2022 Fair Value Forecast
£2.09
2023 Fair Value Forecast
£2.87
2024 Fair Value Forecast
£1.88
2025 Fair Value Forecast
£1.91
2026 Fair Value Forecast
£2.06
2027 Fair Value Forecast
£2.36
2028 Fair Value Forecast
£2.19
2029 Fair Value Forecast
£2.10
2030 Fair Value Forecast
£2.10
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$344.15 $333.19 16.23%
PFE Stock Forecast Pfizer Inc Outperform 3
$44.16 $53.97 19.23%
AZN Stock Forecast AstraZeneca PLC Outperform 8
£10.59k £153.20 -98.53%
GMAB Stock Forecast Genmab A/S Outperform 16
kr3.00k kr2.84k -8.24%
ARGX Stock Forecast argenx Buy 4
358.10€ 0.00€ -0.31%

Indivior PLC Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's Revenue has grown, increasing from £785.00M to £791.00M – a growth of 0.76%. The next year, 0 experts forecast that Indivior PLC's Revenue will decrease by 5.02%, reaching £751.27M. In 2030, professionals predict that Indivior PLC's Revenue will decrease by 5.03%, reaching £751.19M.

2022 Rev Forecast
£0.75B
2023 Rev Forecast
£0.77B
2024 Rev Forecast
£0.73B
2025 Rev Forecast
£0.75B
2026 Rev Forecast
£0.75B
2027 Rev Forecast
£0.76B
2028 Rev Forecast
£0.75B
2029 Rev Forecast
£0.75B
2030 Rev Forecast
£0.75B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TEVA Stock Forecast Teva Pharmaceutical Industries Hold 12
$10.54 $12.04 -5.12%
REC Stock Forecast Recordati Industria Chimica e ... Hold 18
38.68€ 49.03€ 13.75%
ORNBV Stock Forecast Orion Oyj Hold 14
53.46€ 34.70€ -25.18%

Indivior PLC Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ITCI Stock Forecast Intra-Cellular Therapies Outperform 10
$47.92 $68.92 46.08%
HIK Stock Forecast Hikma Pharmaceuticals PLC Outperform 18
£1.71k £29.33 -98.39%
ALKS Stock Forecast Alkermes Hold 10
$27.11 $0.00 18.04%

Indivior PLC Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's Free Cash Flow has grown by 142.36%, rising from £144.00M to £349.00M. According to 0 prominent analysts, Indivior PLC's Free Cash Flow will fall by 47.54% in the next year, reaching £183.09M. By 2030, professionals believe that Indivior PLC's Free Cash Flow will decrease by 35.42%, reaching £225.38M – a concerning trend for the company.

2022 FCF Forecast
£0.18B
2023 FCF Forecast
£0.25B
2024 FCF Forecast
£0.17B
2025 FCF Forecast
£0.23B
2026 FCF Forecast
£0.23B
2027 FCF Forecast
£0.24B
2028 FCF Forecast
£0.22B
2029 FCF Forecast
£0.22B
2030 FCF Forecast
£0.23B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LUN Stock Forecast H. Lundbeck A/S Outperform 18
kr23.88 kr224.81 716.58%
ALK B Stock Forecast ALK-Abelló A/S Hold 13
kr96.05 kr3.35k 84.80%
EVT Stock Forecast Evotec Outperform 14
18.92€ 37.33€ 74.42%

Indivior PLC Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's Net Income has grown from £134.00M to £205.00M – a 52.99% increase. For the next year, 0 analysts project Indivior PLC's Net Income to drop by 51.29%, reaching £99.86M. By 2030, professionals believe that Indivior PLC's Net Income will decrease by 36.85%, reaching £129.46M – a concerning trend for the company.

2022 NI Forecast
£0.10B
2023 NI Forecast
£0.14B
2024 NI Forecast
£0.10B
2025 NI Forecast
£0.14B
2026 NI Forecast
£0.13B
2027 NI Forecast
£0.14B
2028 NI Forecast
£0.12B
2029 NI Forecast
£0.13B
2030 NI Forecast
£0.13B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALM Stock Forecast Almirall Outperform 16
9.26€ 14.28€ 51.19%
CLIN Stock Forecast Clinigen Group Outperform 18
£9.25 £7.78 75.89%
FAE Stock Forecast Faes Farma Hold 18
3.44€ 4.20€ 22.09%

Indivior PLC EBITDA Forecast for 2023 - 2025 - 2030

Indivior PLC's EBITDA has decreased In the last two years, from £214.00M to £198.00M – a 7.48% drop. For next year, analysts predict EBITDA of £207.17M, which would mean an increase of 4.63%. Over the next nine years, experts predict that Indivior PLC's EBITDA will grow at a rate of 3.34%.

2022 EBITDA Forecast
£0.21B
2023 EBITDA Forecast
£0.25B
2024 EBITDA Forecast
£0.19B
2025 EBITDA Forecast
£0.20B
2026 EBITDA Forecast
£0.20B
2027 EBITDA Forecast
£0.22B
2028 EBITDA Forecast
£0.21B
2029 EBITDA Forecast
£0.20B
2030 EBITDA Forecast
£0.20B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
VEC Stock Forecast Vectura Group Hold 14
£165.00 £1.41 -98.88%
PHM Stock Forecast Pharma Mar Outperform 13
60.52€ 0.00€ 35.82%
COPN Stock Forecast Cosmo Pharmaceuticals N.V. Buy 12
CHF56.10 CHF0.00 65.54%

Indivior PLC EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's EBIT has seen a drop from £202.00M to £186.00M – a 7.92% decrease. In the next year, analysts believe that EBIT will reach £200.99M – an increase of 8.06%. For the next nine years, the forecast is for EBIT to grow by 6.72%.

2022 EBIT Forecast
£0.20B
2023 EBIT Forecast
£0.25B
2024 EBIT Forecast
£0.18B
2025 EBIT Forecast
£0.19B
2026 EBIT Forecast
£0.20B
2027 EBIT Forecast
£0.22B
2028 EBIT Forecast
£0.20B
2029 EBIT Forecast
£0.20B
2030 EBIT Forecast
£0.20B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ZEAL Stock Forecast Zealand Pharma A/S Outperform 8
kr117.00 kr241.83 70.94%
MOR Stock Forecast MorphoSys Outperform 6
18.38€ 40.70€ 87.70%
VNDA Stock Forecast Vanda Pharmaceuticals Hold 0
$7.60 $24.00 31.58%

Indivior PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Indivior PLC's EPS has decreased from £0.23 to £0.18 – a 21.74% drop! The next year looks promising for Indivior PLC, with analysts predicting EPS of £0.23 – an increase of 25.46%. Over the next nine years, experts anticipate that Indivior PLC's EPS will grow at a rate of 26.02%.

2022 EPS Forecast
£0.23
2023 EPS Forecast
£0.31
2024 EPS Forecast
£0.20
2025 EPS Forecast
£0.21
2026 EPS Forecast
£0.22
2027 EPS Forecast
£0.26
2028 EPS Forecast
£0.24
2029 EPS Forecast
£0.23
2030 EPS Forecast
£0.23
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NasdaqGS:BDSI Stock Forecast BioDelivery Sciences Internati... - 11
$5.59 $10.00 78.89%
BSLN Stock Forecast Basilea Pharmaceutica Buy 6
CHF42.26 CHF87.60 72.74%
DBV Stock Forecast DBV Technologies Outperform 5
4.48€ 12.23€ -11.83%